The Differential Diagnosis of Sinonasal/Nasopharyngeal Neuroendocrine/Neuroectodermally Derived Tumors
|
|
- Austin Elliott
- 6 years ago
- Views:
Transcription
1 The Differential Diagnosis of Sinonasal/Nasopharyngeal Neuroendocrine/Neuroectodermally Derived Tumors Kathleen T. Montone, MD Context. The differential diagnosis of neuroendocrine neoplasms arising in the sinonasal tract is broad and includes lesions of epithelial, mesenchymal, and neuroectodermal origin. Objective. To review the differential diagnosis of sinonasal neuroendocrine and neuroectodermally derived tumors. Data Sources. The current literature was reviewed to provide updated information regarding the differential diagnosis and means for diagnosing neuroendocrine tumors including sinonasal neuroendocrine carcinoma, olfactory neuroblastoma, malignant melanoma, paraganglioma, pituitary adenoma, and Ewing family of tumors. Conclusions. The differential diagnosis of neoplasms with neuroendocrine differentiation in the sinonasal tract is broad, and diagnosis often includes not only histologic review but also immunohistochemical or molecular analysis. (Arch Pathol Lab Med. 2015;139: ; doi: /arpa RA) A variety of different neoplastic tumors including those with epithelial, mesenchymal, or neuroectodermal differentiation may arise in the sinonasal tract and should be considered in the differential diagnosis of sinonasal tract neoplasms. 1 4 Neuroendocrine/neuroectodermally derived sinonasal tumors are often a consideration when a pathologist is reviewing a sinonasal neoplasm (either benign or malignant). This review will describe the differential diagnosis of sinonasal tract neuroendocrine/neuroectodermal neoplasms (Table 1). NEUROENDOCRINE CARCINOMA Epithelial malignancies are the most common malignant tumors of the sinonasal tract; however, carcinomas with neuroendocrine differentiation are exceedingly rare in this site. 1 6 Classification of sinonasal tract neuroendocrine carcinomas is variable. The most common classification system for head and neck neuroendocrine carcinomas is the classification recommended by the World Health Organization (WHO), which is as follows: carcinoid tumor; atypical carcinoid; small cell carcinoma, neuroendocrine type; neuroendocrine carcinoma, not otherwise specified; and combined small cell carcinoma (neuroendocrine type) with non small cell carcinoma (usually adenocarcinoma or squamous cell carcinoma). 7 More recently, consideration Accepted for publication April 20, From the Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia. The author has no relevant financial interest in the products or companies described in this article. Presented in part at The Princeton Integrated Pathology Symposium: Head and Neck Pathology; February 9, 2014; Princeton, New Jersey. Reprints: Kathleen T. Montone, MD, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 3400 Spruce St, 6 Founders, Philadelphia, PA ( kmontone@upenn.edu). for classifying head and neck neuroendocrine carcinomas, using the recommended classifications for neuroendocrine tumors of the lung and pancreas/gastrointestinal tract, has been proposed 8 10 (Table 2). While large cell neuroendocrine carcinoma of the head and neck has not in the past been recognized in the WHO classification, it is established that this lesion does exist, and recent reviews 11 have suggested these lesions should be included in the future WHO classifications of head and neck neuroendocrine carcinomas. Sinonasal neuroendocrine carcinomas have histologic features similar to neuroendocrine carcinomas arising in other sites (Figure 1, A through C). Low- and intermediategrade tumors ( carcinoids and atypical carcinoids ) are extremely rare and limited data are available on these lesions. 10 High-grade lesions are most common and usually classified as small cell carcinoma. 5,6 Mixed neuroendocrine/ adenocarcinomas and neuroendocrine/squamous cell carcinomas have been described. 1 4,12 By immunohistochemistry, neuroendocrine carcinomas variably express cytokeratin and neuroendocrine markers (synaptophysin, neuron-specific enolase, chromogranin, CD56; Figure 1, D). Staining for calcitonin and thyroid transcription factor 1 (TTF-1) is rare in tumors of the sinonasal tract. The prognosis for sinonasal neuroendocrine carcinoma will vary with the tumor types and grades, with high-grade carcinomas having a worse prognosis. Improved survival has been seen in patients with a multimodality approach to treatment OLFACTORY NEUROBLASTOMA (ESTHESIONEUROBLASTOMA) Olfactory neuroblastoma (ONB) is a rare (,5% of sinonasal tract malignancies) malignant tumor of neuroectodermal origin that arises from the olfactory epithelium lining the superior one-third of the nasal septum, the cribriform plate, and the superior nasal turbinates. The 1498 Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone
2 Table 1. The Differential Diagnosis of Neuroendocrine/Neuroectodermal Neoplasms of the Sinonasal Tract Neuroendocrine carcinoma Well differentiated (carcinoid) Moderately differentiated (atypical carcinoid) Poorly differentiated (small cell carcinoma or large cell neuroendocrine carcinoma) Olfactory neuroblastoma/esthesioneuroblastoma Malignant melanoma Ewing family of tumors (Ewing sarcoma/pnet) Paraganglioma Pituitary adenoma Abbreviation: PNET, primitive neuroectodermal tumor. Table 2. Proposed Sinonasal Neuroendocrine Carcinoma Classification 1. Well-differentiated neuroendocrine tumor/neuroendocrine carcinoma, grade 1 (carcinoid morphology;,2 mitoses per 10 HPFs; no necrosis) 2. Moderately differentiated neuroendocrine tumor/ neuroendocrine carcinoma, grade 2 (atypical carcinoid; 2 10 mitoses per 10 HPFs and/or necrosis) 3. Poorly differentiated neuroendocrine tumor/neuroendocrine carcinoma, grade 3 (small or large cell carcinoma;.10 mitoses per 10 HPFs; necrosis) Abbreviation: HPFs, high-power fields. tumor affects males and females equally and occurs over a wide age range with a bimodal distribution (ages and years). 1 4 Histologically, ONB characteristically shows a lobular architecture. Well-differentiated ONBs are composed of nests of small cells with uniform, round to oval nuclei and speckled chromatin pattern admixed with a neurofibrillary matrix. In contrast, poorly differentiated ONBs are characterized by cells with hyperchromatic, atypical nuclei with coarse chromatin, scant cytoplasm, and minimal fibrillary matrix (Figure 2, A through D). The best grading system (Hyams classification; Table 3) for ONB includes 4 grades with grade I being the most differentiated and grade IV being the least differentiated. 17 Grade I tumors have a lobular architecture with the presence of a prominent neurofibrillary matrix. The cells are small and cytologically uniform without mitotic activity. Pseudorosettes (Homer- Wright rosettes) are often present and necrosis is not seen. Figure 1. Sinonasal neuroendocrine carcinoma. A, Moderately differentiated (atypical carcinoid). B, Poorly differentiated (small-cell type). C, Poorly differentiated (non small cell). D, Poorly differentiated (non small cell, positive for CD56) (hematoxylin-eosin, original magnifications 350 [A] and 3100 [B and C]; diaminobenzidine with hematoxylin counterstain, original magnification 325 [D]). Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone 1499
3 Figure 2. Olfactory neuroblastoma (ONB). A, Examination shows a cellular small round cell tumor with a nested appearance. B, Olfactory neuroblastoma showing medium-sized cells surrounded by neurofibrillary matrix. C, High-power view of ONB showing bland, hyperchromatic nuclei without prominent nucleoli. D, Low-power view of ONB shows a cellular small round cell neoplasm with numerous blood vessels. E, Olfactory neuroblastoma showing positive staining for chromogranin. F, Olfactory neuroblastoma showing sustentacular cell staining pattern with S100 immunostain (hematoxylin-eosin, original magnifications 3100 [A through C] and 350 [D]; diaminobenzidine with hematoxylin counterstain, original magnifications 350 [E] and 3100 [F]) Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone
4 Grade Table 3. Lobular Architecture Preservation Hyams Grading System for Olfactory Neuroblastoma Mitotic Index Nuclear Pleomorphism Fibrillary Matrix Rosettes Necrosis I Present Zero None Prominent HW rosettes None II Present Low Low Present HW rosettes None III May or may not be present Moderate Moderate Low FW rosettes Rare IV May or may not be present High High Absent None Frequent Abbreviations: FW, Flexner-Wintersteiner; HW, Homer-Wright. Figure 3. A, Sinonasal melanoma infiltrating the sinonasal submucosa. This tumor has a more epithelial cytologic appearance. B, Sinonasal melanoma showing large atypical epithelioid-type cells with abundant eosinophilic cytoplasm and prominent nucleoli. This melanoma was a recurrence, with the original primary tumor occurring 16 years prior. C, Sinonasal melanoma showing a spindle cell morphology and necrosis. D, Sinonasal melanoma showing a small round cell morphology. Scattered melanin pigment is also seen in this case. E, Sinonasal melanoma with a small round cell morphology. This case was originally classified by an outside hospital as olfactory neuroblastoma but was reclassified as melanoma on re-review and additional immunohistochemical staining (hematoxylin-eosin, original magnifications 3100 [A, C, D, and E] and 3200 [B]). Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone 1501
5 Figure 4. Ewing family of tumors. A, Low-power view of a core biopsy of a maxillary sinus mass in a 16-year-old adolescent boy, showing nests of small round blue cells. B, Higher-power view showing a monotonous neoplasm without significant mitotic activity or necrosis. C, Immunohistochemistry for FLI1 reveals strong nuclear expression. EWS1 rearrangements were confirmed by fluorescence in situ hybridization studies (hematoxylin-eosin, original magnifications 325 [A] and 3100 [B]; diaminobenzidine with hematoxylin counterstain, original magnification 3100 [C]). Figure 5. Paraganglioma. A, Low-power view of a sinonasal paraganglioma showing nested appearance. B, Higher-power view of a paraganglioma showing nuclear size variation with bland nuclei and no mitotic activity (hematoxylin-eosin, original magnifications 350 [A] and 3100 [B]) Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone
6 Figure 6. Ectopic parathyroid adenoma (PA). A, Low-power view of PA in the sphenoid sinus. B, Higher-power view of PA showing cells with small round nuclei and no atypia. C, Growth hormone expression in PA. D, Ectopic PA with more epithelioid morphology. E, Ectopic PA expressing prolactin (hematoxylin-eosin, original magnifications 325 [A] and 3100 [B and D]; diaminobenzidine with hematoxylin counterstain, original magnification 3100 [C and E]). Grade II tumors usually show less prominent matrix and more cellular atypia with mitoses. Grade III tumors may retain a lobular architecture but the cells are more atypical with increased mitoses and necrosis. True neural rosettes Arch Pathol Lab Med Vol 139, December 2015 (Flexner-Wintersteiner) may be present. Grade IV tumors are the most undifferentiated and difficult to diagnose because there is often loss of lobular architecture. Cytologic atypia, necrosis, and mitotic activity are often present. Sinonasal Neuroendocrine Tumors Montone 1503
7 Table 4. Different Diagnosis of Sinonasal Neuroendocrine/Neuroectodermal Tumors Diagnosis Incidence, % of All Sinonasal Tract Malignancies Clinical Features Histologic Features SNEC, grade 1,1 Nasal obstruction, epistaxis, headache, sinusitis Similar to carcinoid tumors in other sites SNEC, grade 2,1 M. F Nasal obstruction, epistaxis, headache, sinusitis SNEC, grade 3,1 M ¼ F Nasal obstruction, epistaxis, headache, sinusitis ONB 5 F. M Nasal obstruction, epistaxis, anosmia, headache Melanoma 5 M. F Obstruction, mass, pain, epistaxis Histologically similar to atypical carcinoid tumors in other sites Histologically similar to small cell carcinomas in other sites Low-grade tumors show lobular/nested architecture, neurofibrillary matrix, low mitotic rate, no necrosis, pseudorosettes (Homer-Wright); high-grade tumors show loss of lobular/nested architecture, necrosis, mitoses, atypia, minimal neurofibrillary matrix, true neural rosettes (Flexner-Winsteiner) Variable histology: epithelioid, spindle cell, small cell 50% amelanotic PNET/Ewing sarcoma Unknown, likely,1% Nasal obstruction, epistaxis Small round cells; bland nuclei; low mitotic rate, focal necrosis Paraganglioma,1 Polypoid lesion, epistaxis, obstructive mass, headache; rare tumors are functioning... Pituitary adenoma NA Abbreviations: EWS, Ewing sarcoma; F, female; HPF, high-power field; IHC, immunohistochemistry; M, male; NA, not applicable; NEC, neuroendocrine carcinoma; NSE, neuron-specific enolase; ONB, olfactory neuroblastoma; PNET, primitive neuroectodermal tumor; SDHB, succinate dehydrogenase subunit B; SNEC, sinonasal neuroendocrine carcinoma; TTF-1, thyroid transcription factor 1. Hyams grade I and II tumors are most often considered low grade and Hyams grade III to IV are high grade By immunohistochemistry, ONBs are positive for neuronspecific enolase, chromogranin, synaptophysin, and CD56 (Figure 2, E). S100 highlights the peripheral sustentacular cells (Figure 2, F). Tumors are rarely positive for cytokeratin. A recent study has shown that ONBs are frequently strongly positive for calretinin and negative for p63 and this immunohistochemical phenotype helps differentiate ONBs from other small round cell neoplasms. 20 Prognostic factors include Hyams grade, neck lymph node metastasis, and distant metastasis. 18,19 While ONB should be considered in the differential diagnosis of small round cell tumors of the sinonasal tract, there could be a tendency to overdiagnose small round cell tumors of the head and neck as ONBs. In a 2002 study from The University of Texas MD Anderson Cancer Center (Houston) the investigators felt that round cell tumors in the sinonasal tract may be overdiagnosed as ONB. 21 In their study of 12 patients originally given the diagnosis of ONB at an outside institution, they agreed with the ONB diagnosis in only 2 instances. For the patients they felt had been misdiagnosed, there was significant variation in treatment with increased patient morbidity in 8 patients. The tumors that had been initially misdiagnosed as ONBs included malignant melanoma (2), neuroendocrine carcinoma (3), pituitary adenoma (3), and sinonasal undifferentiated carcinoma (2). MALIGNANT MELANOMA Sinonasal melanoma is an uncommon tumor constituting about 5% of all neoplasms of the sinonasal tract and less than 5% of all melanomas. 1 4,21 24 Melanoma of the sinonasal tract has an equal incidence in males and females and is more commonly seen in patients older than 40 years. In the nasal cavity, tumors are most commonly encountered on the septum followed by the lateral nasal wall and the middle and inferior turbinates. The maxillary sinus is the most common paranasal sinus affected. The risk factors for sinonasal melanomas are largely unknown. Mucosal melanosis is associated with tumor development in oral sites but has only rarely been documented in patients with sinonasal melanoma. An autopsy study 25 found that melanocytes are normally present in the sinonasal mucosa and the number of these cells increases with age, perhaps explaining a reason why sinonasal melanomas are rarely encountered in younger patients and show increased incidence with increasing age. Microscopically, as with cutaneous melanomas, sinonasal mucosal melanomas may take on a variety of histologic appearances 1 4,21 24 (Figure 3, A through E). Lesional cells can be spindled or epithelioid and a mixture of both cell types can also be seen. Spindle cell melanomas are 1504 Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone
8 Table 4. Extended Immunohistochemistry Prognosis Comments Positive for cytokeratin, synaptophysin, chromogranin, NSE, CD56 Positive for cytokeratin, synaptophysin, chromogranin, NSE, CD56; may rarely express calcitonin and TTF-1 Positive for cytokeratin, synaptophysin, chromogranin, NSE, CD56 Unknown due to rarity reported survival at 5 y, approximately 60% 70%, based on small numbers Unknown due to rarity reported survival at 5 y, approximately 60 70%, based on small numbers Survival generally,18 mo Low mitotic rate (,2 mitoses in 10 HPFs) and no necrosis Mitoses 2 10 in 10 HPFs and/or necrosis Mitoses. 10 in 10 HPFs; may be small cell or large cell in type Positive for chromogranin, NSE, synaptophysin, S100 (sustentacular pattern), CD56, calretinin Rarely positive for cytokeratin Negative for p63 5-y survival:.70%, based on stage and grade Pathologically graded with Hyams grading (grade 1 4); grades 1 and 2 are low grade and grades 3 and 4 are high grade; staged with Kadish grading system (stage A, B, and C) Positive for S100, HMB-45, Melan-A, tyrosinase Rare positivity for cytokeratin, myogenin, desmin Positive for vimentin, CD99, FLI1 6 Positivity for neuroendocrine markers, cytokeratins, S100 Negative for desmin Positive for chromogranin, synaptophysin, NSE, S100 (sustentacular pattern) Negative for cytokeratin Positive for cytokeratin (pan-cytokeratin, CAM 5.2), synaptophysin, chromogranin, pituitary hormones (singly or multiply, most common is prolactin) 5-y survival:,30% Rarely show BRAF mutations; more commonly demonstrate NRAS and c- KIT mutations Unknown; possibly better than Ewing family of tumors in other sites Predicted risk of malignancy approximately 25% Too small patient numbers to determine survival rates NA Most show rearrangement of the EWS gene on chromosome 22 most commonly with the FLI1 gene on chromosome 11 May be associated with mutations in genes coding for succinate dehydrogenase subunits, particularly SDHB Often can be confused with low-grade NEC and low-grade ONB; IHC for pituitary hormones can aid in the diagnosis composed of pleomorphic spindle cells with hyperchromatic nuclei, which may or may not contain prominent nucleoli. Epithelioid melanoma may grow in a solid, nested, or trabecular pattern and is characterized by large pleomorphic, epithelioid cells; abundant eosinophilic cytoplasm; and nuclei with prominent cherry red nucleoli and nuclear pseudoinclusions. In addition, sinonasal melanomas may be composed of small round cells with scant cytoplasm and can be misdiagnosed as small cell carcinomas or ONB. While a clue to diagnosis is intracytoplasmic melanin pigment, sinonasal melanomas are often amelanotic. Pagetoid spread (melanoma in situ) into the overlying respiratory mucosa may be present, although primary lesions are often not identified Immunohistochemistry for melanoma markers such as S100, HMB-45, and Melan-A, are useful for establishing the diagnosis. While BRAF mutations are characteristic of cutaneous melanomas, their presence is rare in sinonasal melanomas; however, sinonasal melanomas have been shown to harbor NRAS (and rarely c-kit) mutations Most patients (but not all) with sinonasal melanoma have a poor prognosis with a reported 5-year survival rate of less than 20% There are rare cases of patients with longterm survival, and recurrences as late as 20 years after primary diagnosis may be seen. Prognostic factors for sinonasal mucosal melanomas have not been as widely studied as for cutaneous lesions, most likely because these lesions are rare and often present late in the disease course. EWING FAMILY OF TUMORS (PRIMITIVE NEUROECTODERMAL TUMOR/EWING SARCOMA) The Ewing family of tumors consists of aggressive malignancies that can rarely arise in the sinonasal tract. 1 4,29 They are most commonly seen in children and young adults with a male predominance. Approximately 40% of cases present with maxillary sinus involvement. Microscopically, these tumors are characterized by sheets of monotonous cells with individual cell necrosis, and inconspicuous nucleoli (Figure 4, A and B). Foci of coagulative necrosis may be seen. Periodic acid Schiff stain shows the presence of cytoplasmic glycogen. By immunohistochemistry, almost all tumors express vimentin and MIC2 (CD99). Some tumors may express neuron-specific enolase and synaptophysin. Rare tumors express cytokeratin, S100, and glial fibrillary acid protein (GFAP). Desmin stains negatively. Approximately 85% of primitive neuroectodermal tumors (PNETs)/Ewing sarcomas show a characteristic translocation involving fusion of the EWS gene on chromosome 22 with the FLI1 gene on chromosome 11 (t(11;22)(q24;q12)). 1 4,29 The FLI1 protein product produced by the fusion transcript can be detected by immunohistochemistry (Figure 4, C). While PNETs/Ewing sarcomas are aggressive neoplasms, recent data suggest a better prognosis for those in the sinonasal tract. 29 PARAGANGLIOMA Paragangliomas (PGLs) of head and neck sites are uncommon, representing less than 1% of all tumors in the Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone 1505
9 head and neck area, with most of these tumors arising in the carotid body or jugular bulb. 30 Sinonasal/nasopharyngeal PGLs are very rare and while usually not functional, they may present with elevation of catecholamines. 31,32 Histologically, PGLs are characterized by a nested ( zellballen ) appearance of neuroendocrine cells surrounded by a fine vascular network (Figure 5, A and B). The tumor cell nests are usually smaller than those seen in ONB. Cytologically, PGL tumor cells are large, polygonal and have abundant eosinophilic/metachromatic granular cytoplasm, and uniform nuclei with open chromatin. The distinction between benign and malignant PGLs cannot be made without evidence of metastasis. Malignant neoplasms, however, more commonly have necrosis, vascular invasion, and mitotic activity. By immunohistochemistry, PGLs are positive for chromogranin and synaptophysin. S100 highlights the sustentacular cells similarly to ONB. Paragangliomas are negative for cytokeratin. Recently studies 33 have shown expression of GATA-3 in PGLs. Most recent studies on PGLs have concentrated on genetic syndromes associated with PGL In fact, it is believed that up to 50% of head and neck PGLs may be associated with a genetic syndrome. To date more than 10 susceptibility genes have been identified in patients with PGL, including, most commonly, mutations in the genes coding for succinate dehydrogenase subunits (SDHA, SDHB, SDHC, SDHD) and mutations in VHL, RET, and NF1. 36 The association of PGLs with germline SDHB mutations has been of recent interest. Most patients with SDHB mutations have extra-adrenal tumors with most located in the pelvis, abdomen, and head and neck areas. 36 Most patients are in their third decade of life at presentation, with almost 100% penetrance by age 70 years. 36 Patients with SDHB mutations have an increased risk of having malignant/recurrent PGLs, and SDHB mutations have also been associated with gastrointestinal stromal tumors, papillary thyroid carcinomas, and renal cell carcinomas. 36 Screening for SDHB mutations can be performed by using immunohistochemistry for SDHB, with loss of expression being associated with mutation. 37 Mutations in other genes encoding SDH subunits, particularly SDHD, have also been associated with head and neck paragangliomas, but paragangliomas associated with SDHD mutations are almost always benign. 36 PITUITARY ADENOMA Pituitary adenomas may rarely involve the sinonasal tract either by direct extension from an intracranial lesion or ectopically (likely arising from remnants of Rathke pouch). Lesions can be seen in males or females and can present at any age. Most commonly, ectopic pituitary adenomas are located in the sphenoid sinus but may locally extend into the nasal cavity and nasopharyngeal area. 38,39 Histologically, ectopic pituitary adenomas resemble intracranial pituitary adenomas. The lesional cells can take on a variety of different growth patterns including nested, trabecular, and glandular patterns 39 (Figure 6, A, B, and D). A fine vascular network is often seen surrounding tumor cell nests. Cytologically, the pituitary adenoma cells are often polygonal with granular eosinophilic or basophilic cytoplasm and finely speckled chromatin pattern. Mitotic activity is almost never seen but rarely necrosis may be present. By immunohistochemistry, the lesional cells are Table 5. Immunohistochemistry in the Differential Diagnosis of Sinonasal Neuroendocrine Tumors Sinonasal neuroendocrine carcinoma Cytokeratin: positive Neuroendocrine markers (synaptophysin, chromogranin, CD56): positive S100: variable Other melanoma markers (Melan-A, HMB-45, tyrosinase): negative Olfactory neuroblastoma Cytokeratin: usually negative (rare cases positive) Neuroendocrine marker: positive S100: sustentacular pattern of staining Other melanoma markers (Melan-A, HMB-45, tyrosinase): negative Calretinin: positive Malignant melanoma Cytokeratin: usually negative (rare cases positive) S100: positive Other melanoma markers (Melan-A, HMB-45, tyrosinase): positive Ewing family of tumors Cytokeratin: usually negative (rare cases positive) Neuroendocrine markers: variably positive S100: variable Other melanoma markers (Melan-A, HMB-45, tyrosinase): negative CD99: positive FLI1: may be positive Paraganglioma Cytokeratin: negative Neuroendocrine markers: positive S100: sustentacular pattern of staining Other melanoma markers (Melan-A, HMB-45, tyrosinase): negative GATA-3: positive SDHB: loss of expression in patients with SDH mutations Pituitary adenoma Cytokeratin: positive (.80%) Neuroendocrine markers: positive S100: negative Pituitary hormones: positive (most commonly prolactin [60%]) Abbreviation: SDHB, succinate dehydrogenase subunit B. commonly positive for cytokeratin (pan-cytokeratin or CAM 5.2), neuroendocrine markers, and pituitary hormones, which may be expressed singly or multiply with prolactin being the most common hormone produced (60% of cases) 39 (Figure 6, C and E). Pituitary adenoma should come into the differential diagnosis of any low-grade neuroendocrine neoplasm in the sinonasal tract. It is a diagnosis of utmost importance, since these lesions are often positive for cytokeratin and can be classified as lowgrade neuroendocrine carcinomas if not considered in the differential diagnosis of a cytokeratin-positive neuroendocrine tumor of the sinonasal tract. Confirmation of production of pituitary hormones will be useful for establishment of diagnosis. In summary, there are a variety of benign and malignant neoplasms that arise in the sinonasal tract/nasopharyngeal area with neuroendocrine/neuroectodermal differentiation. These lesions can have overlapping clinical and pathologic features and should be considered in the differential diagnosis of sinonasal tract neoplasms (Tables 4 and 5) Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone
10 References 1. Cordes B, Williams MD, Tirado Y, et al. Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. Hum Pathol. 2009;40(3): Wenig BM. Undifferentiated malignant neoplasms of the sinonasal tract. Arch Pathol Lab Med. 2009;133(5): Iezzoni JC, Mills SE. Undifferentiated small round cell tumors of the sinonasal tract: differential diagnosis update [review]. Am J Clin Pathol. 2005; 124(suppl):S110 S Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002;15(3): Perez-Ordonez B, Caruana SM, Huvos AG, Shah JP. Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Hum Pathol. 1998;29(8): Georgiou AF, Walker DM, Collins AP, Morgan GJ, Shannon JA, Veness MJ. Primary small cell undifferentiated (neuroendocrine) carcinoma of the maxillary sinus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(5): Perez-Ordonez B. Neuroendocrine tumors. In: Barnes L, Eveson JW, Reichart P, Sidransky D, eds. Pathology and Genetics of Head and Neck Tumours. Lyon, France: IARC Press; 2005: World Health Organization Classification of Tumours; vol Kao HL, Chang WC, Li WY, Chia-Heng AS, Fen-Yau Li A. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis. Am J Surg Pathol. 2012;36(2): Chetty R, Shah KA, Perez-Ordonez B. Large cell neuroendocrine carcinoma of the head and neck. Am J Surg Pathol. 2012;36(7): Weinreb I, Perez-Ordonez B. Non-small cell neuroendocrine carcinoma of the sinonasal tract and nasopharynx: report of 2 cases and review of the literature. Head Neck Pathol. 2007;1(1): Xu B, Chetty R, Perez-Ordonez B. Neuroendocrine neoplasms of the head and neck: some suggestions for the new WHO classification of head and neck tumors. Head Neck Pathol. 2014;8(1): Franchi A, Rocchetta D, Palomba A, Innocenti DR, Castiglione F, Spinelli G. Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization. Head Neck Pathol. 2015;9(1): Rosenthal DI, Barker JL Jr, El-Naggar AK, et al. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic subtype. Cancer. 2004;101(11): Mitchell EH, Diaz A, Yilmaz T, et al. Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck. 2012;34(10): van der Laan TP, Bij HP, van Hemel BM, et al. The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma. Eur Arch Otorhinolaryngol. 2013;270(9): Fried D, Zanation AM, Huang B, et al. Management of nonesthesioneuroblastoma sinonasal malignancies with neuroendocrine differentiation. Laryngoscope. 2012;122(10): Hyams VJ. Olfactory neuroblastoma (case 6). In: Batsakis JG, Hyams VJ, Morales AR, eds. Special Tumors of the Head and Neck. Chicago: ASCP Press; 1982: Bell D, Saade R, Roberts D, et al. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015;9(1): Jethanamest D, Morris LG, Sikora AG, Kutler DI. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Arch Otolaryngol Head Neck Surg. 2007;133(3): Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol. 2011;35(12): Cohen ZR, Marmor E, Fuller GN, Demonte F. Misdiagnosis of olfactory neuroblastoma. Neurosurg Focus. 2002;12(5): Dauer EH, Lewis JE, Rohlinger AL, Weaver AL, Olsen KD. Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg. 2008;138(3): Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol. 2003;27(5): Tajudeen BA, Vorasubin N, Sanaiha Y, Palma-Diaz MF, Suh JD, Wang MB. Sinonasal mucosal melanoma: 20-year experience at a tertiary referral center. Int Forum Allergy Rhinol. 2014;4(7): Uehara T, Matsubara O, Kasuga T. Melanocytes in the nasal cavity and paranasal sinus: incidence and distribution in Japan. Acta Pathol Jpn. 1987;37(7): Zebary A, Jangard M, Omholt K, Ragnarsson-Olding B, Hansson J. KIT, NRAS and BRAF mutations in sinonasal mucosal melanoma: a study of 56 cases. Br J Cancer. 2013;109(3): Turri-Zanoni M, Medicina D, Lombardi D, et al. Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck. 2013;35(8): Chraybi M, Abd Alsamad I, Copie-Bergman C, et al. Oncogene abnormalities in a series of primary melanomas of the sinonasal tract: NRAS mutations and cyclin D1 amplification are more frequent than KIT or BRAF mutations. Hum Pathol. 2013;44(9): Hafezi S, Seethala RR, Stelow EB, et al. Ewing s family of tumors of the sinonasal tract and maxillary bone. Head Neck Pathol. 2011;5(1): Offergeld C, Brase C, Yaremchuk S, et al. Head and neck paragangliomas: clinical and molecular genetic classification. Clinics (Sao Paulo). 2012;67(suppl 1): Papaspyrou K, Welkoborsky HJ, Gouveris H, Mann WJ. Malignant and benign sinonasal paragangliomas. Laryngoscope. 2013;123(8): Hahn S, Palmer JN, Adappa ND. A catecholamine-secreting skull base sinonasal paraganglioma presenting with labile hypertension in a patient with previously undiagnosed genetic mutation. JNeurolSurgRep. 2012;73(1): So JS, Epstein JI. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. Mod Pathol. 2013;26(10): Schiavi F, Savvoukidis T, Trabalzini F, et al. Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas. Ann N Y Acad Sci. 2006;1073: Boedeker CC, Neumann HP, Maier W, Bausch B, Schipper J, Ridder GJ. Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg. 2007;137(1): Fishbein L, Nathanson KL. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet. 2012;205(1 2): Gill AJ, Benn DE, Chou A, et al. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol. 2010;41(6): Langford L, Batsakis JG. Pituitary gland involvement of the sinonasal tract. Ann Otol Rhinol Laryngol. 1995;104(2): Thompson LD, Seethala RR, Müller S. Ectopic sphenoid sinus pituitary adenoma (ESSPA) with normal anterior pituitary gland: a clinicopathologic and immunophenotypic study of 32 cases with a comprehensive review of the english literature. Head Neck Pathol. 2012;6(1): CAP 16 Abstract Program Submission Dates Announced Abstract and case study submissions to the College of American Pathologists (CAP) 2016 Abstract Program will be accepted beginning on Friday, January 8 through 5 p.m. Central time Friday, March 11, Accepted submissions will appear on the Archives of Pathology & Laboratory Medicine Web site as a Web-only supplement to the September 2016 issue. The CAP 16 meeting will be held from September 25 to 28 in Las Vegas, Nevada. Visit the CAP 16 Web site ( for additional abstract program information as it becomes available. Arch Pathol Lab Med Vol 139, December 2015 Sinonasal Neuroendocrine Tumors Montone 1507
Small (and large) Blue Cell Tumors of the Skull Base
Small (and large) Blue Cell Tumors of the Skull Base Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for
More informationCase 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset
Case 2 Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset History 24 year old male presented with a 3 day history of right flank pain, sharp in nature Denies fever, chills, hematuria or
More informationNutn but a Small Biopsy How to approach small biopsy samples of the sinonasal tract
California Society of Pathology Saturday Slide Seminar Nutn but a Small Biopsy How to approach small biopsy samples of the sinonasal tract Lester D. R. Thompson www.lester-thompson.com Learning Objectives
More informationSarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia
Case Report Sarcomatoid (spindle cell) carcinoma of the cricopharynx presenting as dysphagia Jagtap Sunil V. 1, Shukla Dhirajkumar B. 2, Jagtap Swati S. 3, Havle Abhay D. 4 1 Associate Professor, Department
More informationNasal Cavity and Paranasal Sinuses
Chapter 2 Nasal Cavity and Paranasal Sinuses Introduction Included in this chapter are nasal cavities, frontal sinus, ethmoid complex, sphenoid sinus, and maxillary sinuses. These cavities and sinuses
More informationEnterprise Interest Nothing to declare
Enterprise Interest Nothing to declare Diagnoses one would not like to miss in soft tissue pathology early in your career Marta Sbaraglia, MD Department of Pathology Hospital of Treviso University of Padua
More informationCase: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on
Case: The patient is a 24 year- old female who was found to have multiple mural nodules within the antrum. Solid and cystic components were noted on imaging. There is no significant past medical history.
More informationProblem 1: Differential of Neuroendocrine Carcinoma 3/23/2017. Disclosure of Relevant Financial Relationships
Differential of Neuroendocrine Carcinoma Alain C. Borczuk,MD Weill Cornell Medicine Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control
More informationJ of Evolution of Med and Dent Sci/ eissn , pissn / Vol. 3/ Issue 30/July 28, 2014 Page 8403
BENIGN TUMOR OF NOSE AND PARANASAL SINUS IN A CHILD: A CASE REPORT Mujtaba Khan 1, S. Muneeruddin Ahmed 2, A. Sesha Prasad 3, M. Mahendra Kumar 4, G. Shahul Hameed 5 HOW TO CITE THIS ARTICLE: Mujtaba Khan,
More information1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma
2016 MFMER slide-1 2016 MFMER slide-2 2016 MFMER slide-3 Soft Tissue Tumors Showing Melanocytic Differentiation Andrew L. Folpe, M.D. Professor of Laboratory Medicine and Pathology Mayo Clinic, Rochester,
More informationClinical analysis of 29 cases of nasal mucosal malignant melanoma
1166 Clinical analysis of 29 cases of nasal mucosal malignant melanoma HUANXIN YU and GANG LIU Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China
More informationA Century of observations
PARAGANGLIOMAS OF THE HEAD & NECK: AN OVERVIEW Michelle D. Williams, MD Associate Professor Dept. of Pathology Head & Neck Section UT MD Anderson Cancer Center Disclosure of Relevant Financial Relationships
More informationMody. AIS vs. Invasive Adenocarcinoma of the Cervix
Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive
More informationCase year old female presented with asymmetric enlargement of the left lobe of the thyroid
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationCase 4 Diagnosis 2/21/2011 TGB
Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.
More informationSpecial slide seminar
Special slide seminar Tomáš Rozkoš The Fingerland Department of Pathology Charles University Medical Faculty and Faculty Hospital in Hradec Králové Czech Republic Case history, 33 years old resistance
More informationDesmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
More informationRespiratory Tract Cytology
Respiratory Tract Cytology 40 th European Congress of Cytology Liverpool, UK Momin T. Siddiqui M.D. Professor of Pathology and Laboratory Medicine Director of Cytopathology Emory University Hospital, Atlanta,
More informationNeuroendocrine Carcinoma. Lebanon Neuroendocrine Neoplasms of H&N Nov /7/2011. Broad Classification:
H&N Neuroendocrine Neoplasms: Classification and Diagnostic Considerations Adel K. El-Naggar, M.D., Ph.D. The University of Texas MD Anderson Cancer Center, Houston, Texas Broad Classification: A. Epithelial:
More informationFinancial disclosures
Mesenchymal Neoplasms with Melanocytic Differentiation By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchcock Medical Center Geisel
More informationNasal mucosal melanosis may act as a harbinger of melanoma: A case report
Nasal mucosal melanosis may act as a harbinger of melanoma: A case report The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation
More information57th Annual HSCP Spring Symposium 4/16/2016
An Unusual Malignant Spindle Cell Lesion to Involve the Breast Erinn Downs-Kelly, D.O. Associate Professor of Pathology University of Utah & ARUP Laboratories No disclosures Case 39 y/o female with no
More informationNeuroendocrine Lung Tumors Myers
Diagnosis and Classification of Neuroendocrine Lung Tumors Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of Michigan, Ann Arbor, MI myerjeff@umich.edu
More informationRenal tumours: use of immunohistochemistry & molecular pathology. Dr Lisa Browning John Radcliffe Hospital Oxford
Renal tumours: use of immunohistochemistry & molecular pathology Dr Lisa Browning John Radcliffe Hospital Oxford Renal tumours: the use of immunohistochemistry & molecular pathology Classification of RCC
More informationWhat s New in Pathology of Genitourinary Tumors. Jiaoti Huang, MD, PhD Department of Pathology Duke University School of Medicine
What s New in Pathology of Genitourinary Tumors Jiaoti Huang, MD, PhD Department of Pathology Duke University School of Medicine Kidney Tumors Multilocular cystic renal neoplasm of low malignant potential
More informationSalivary Glands 3/7/2017
Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationSmall Cell Carcinoma ex-pleomorphic Adenoma of the Parotid Gland
Head and Neck Pathol (2012) 6:502 506 DOI 10.1007/s12105-012-0376-1 CASE REPORT Small Cell Carcinoma ex-pleomorphic Adenoma of the Parotid Gland Ashley Cimino-Mathews Brian M. Lin Steven S. Chang Kofi
More informationClinicopathological Analysis of Undifferentiated Malignant Neoplasms of The Sinonasal Tract
Original Article DOI: 10.21276/APALM.1417 Clinicopathological Analysis of Undifferentiated Malignant Neoplasms of The Sinonasal Tract Ashok kumar S 1 *, Srigayathri S 2 and Geetha Devadas 1 1 Department
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More informationDisclosures. The Thin Red Line Between Neuropathology and Head & Neck Pathology. Introduction CASE 1. Current Issues Tihan
Disclosures I have nothing to disclose The Thin Red Line Between Neuropathology and Head & Neck Pathology Tarik Tihan, MD, PhD UCSF, Department of Pathology Neuropathology Division Introduction Three cases
More informationNine cases of carcinoma with neuroendocrine features in the head and neck: clinicopathological characteristics and clinical outcomes
Japanese Journal of Clinical Oncology, 2015, 45(4) 328 335 doi: 10.1093/jjco/hyv008 Advance Access Publication Date: 10 February 2015 Original Article Original Article Nine cases of carcinoma with neuroendocrine
More informationLow-Grade Papillary Schneiderian Carcinoma: A Case Report
DOI 10.1007/s12105-017-0832-z CASE REPORT Low-Grade Papillary Schneiderian Carcinoma: A Case Report Hui Jeong Jeong 1 Jin Roh 1 Bong Jae Lee 2 Kyung Ja Cho 1 Received: 13 March 2017 / Accepted: 13 June
More informationNeoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath
Neoplasia 2018 Lecture 2 Dr Heyam Awad MD, FRCPath ILOS 1. List the differences between benign and malignant tumors. 2. Recognize the histological features of malignancy. 3. Define dysplasia and understand
More informationCNS pathology Third year medical students. Dr Heyam Awad 2018 Lecture 12: CNS tumours 2/3
CNS pathology Third year medical students Dr Heyam Awad 2018 Lecture 12: CNS tumours 2/3 Pilocytic astrocytoma Relatively benign ( WHO grade 1) Occurs in children and young adults Mostly: in the cerebellum
More informationPulmonary Salivary Gland Type Tumors With Features of Malignant Mixed Tumor (Carcinoma Ex Pleomorphic Adenoma) A Clinicopathologic Study of Five Cases
Anatomic Pathology / Pulmonary Salivary Gland Type Tumors Pulmonary Salivary Gland Type Tumors With Features of Malignant Mixed Tumor (Carcinoma Ex Pleomorphic Adenoma) A Clinicopathologic Study of Five
More information59 yo male with past medical history of prostate carcinoma, presented with upper abdominal pain
December 2016 59 yo male with past medical history of prostate carcinoma, presented with upper abdominal pain Contributed by: Divya Sharma, MD. Fellow, Gastrointestinal Pathology, Department of Pathology
More informationPathology of the Thyroid
Pathology of the Thyroid Thyroid Carcinoma Arising from Follicular Cells 2015-01-19 Prof. Dr. med. Katharina Glatz Pathologie Carcinomas Arising from Follicular Cells Differentiated Carcinoma Papillary
More informationAmong the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews
Resident Short Reviews Inflamed conjunctival nevi (ICN) may suggest malignancy because of their rapid growth and atypical histology. The objective of this study was to characterize the diagnostic features
More informationFINALIZED SEER SINQ QUESTIONS
0076 Source 1: WHO Class CNS Tumors pgs: 33 MP/H Rules/Histology--Brain and CNS: What is the histology code for a tumor originating in the cerebellum and extending into the fourth ventricle described as
More informationPleomorphic adenoma of breast - a case report and distinction with metaplastic carcinoma D Gupta, S Agrawal, N Trivedi, A Tewari
of breast - a case report and distinction with metaplastic carcinoma D Gupta, S Agrawal, N Trivedi, A Tewari Introduction, also known as mixed tumour, is a benign tumour which typically presents as a painless,
More informationPitfalls in thyroid tumor pathology. Prof.Valdi Pešutić-Pisac MD, PhD
Pitfalls in thyroid tumor pathology Prof.Valdi Pešutić-Pisac MD, PhD Too many or... Tumour herniation through a torn capsule simulating capsular invasion fibrous capsule with a sharp discontinuity, suggestive
More informationPitfalls in Sinonasal Pathology
Pitfalls in Sinonasal Pathology Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical Sciences jhunt2@uams.edu
More informationDIAGNOSTIC DILEMMA. Case Reports Clinical history. Materials and Methods
DIAGNOSTIC DILEMMA A Metastatic Renal Carcinoid Tumor Presenting as Breast Mass: A Diagnostic Dilemma Farnaz Hasteh, M.D., 1 Robert Pu, M.D., Ph.D., 2 and Claire W. Michael, M.D. 2 * We present clinicopathological
More informationCase Report SMARCB1 (INI1)-deficient sinonasal carcinoma: a newly described entity
Int J Clin Exp Pathol 2016;9(3):3454-3458 www.ijcep.com /ISSN:1936-2625/IJCEP0024095 Case Report SMARCB1 (INI1)-deficient sinonasal carcinoma: a newly described entity Ming Zeng 1*, Changrong Chen 2*,
More informationDifficult Diagnoses and Controversial Entities in Neoplastic Lung
Difficult Diagnoses and Controversial Entities in Neoplastic Lung Lynette M. Sholl, M.D. Associate Pathologist, Brigham and Women s Hospital Chief, Pulmonary Pathology Service Associate Professor, Harvard
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationCase Scenario 1: Thyroid
Case Scenario 1: Thyroid History and Physical Patient is an otherwise healthy 80 year old female with the complaint of a neck mass first noticed two weeks ago. The mass has increased in size and is palpable.
More informationACCME/Disclosures. Cribriform Lesions of the Prostate. Case
Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires
More informationUniversity Journal of Pre and Para Clinical Sciences
ISSN 2455 2879 Volume 2 Issue 1 2016 Metaplastic carcinoma breast a rare case report Abstract : Metaplastic carcinoma of the breast is a rare malignancy with two distinct cell lines described as a breast
More informationNeuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification
PATHOLOGICA 2017;109:14-30 Review - Study Group GIPaTeC Neuroendocrine neoplasms of the head and neck and olfactory neuroblastoma. Diagnosis and classification S. UCCELLA 1, G. OTTINI 1, C. FACCO 2, R.
More informationSinonasal carcinomas ARTICLE IN PRESS. Lester D.R. Thompson MINI-SYMPOSIUM: HEAD AND NECK PATHOLOGY. Introduction
Current Diagnostic Pathology (2006) 12, 40 53 www.elsevier.com/locate/cdip MINI-SYMPOSIUM: HEAD AND NECK PATHOLOGY Sinonasal carcinomas Lester D.R. Thompson Southern California Permanente Medical Group,
More informationImmunohistochemical Evaluation of Necrotic Malignant Melanomas
Anatomic Pathology / EVALUATION OF NECROTIC MALIGNANT MELANOMAS Immunohistochemical Evaluation of Necrotic Malignant Melanomas Daisuke Nonaka, MD, Jordan Laser, MD, Rachel Tucker, HTL(ASCP), and Jonathan
More informationSMALL CELL NEUROENDOCRINE CARCINOMA OF ETHMOID SINUS: CASE REPORT AND LITERATURE REVIEW
Therapeut Radiol Oncol 2003; 10(3): 175-179 175 SMALL CELL NEUROENDOCRINE CARCINOMA OF ETHMOID SINUS: CASE REPORT AND LITERATURE REVIEW Forn-Chia Lin 1, Li-Ching Lin 1, Chang-Chuan Su 2, Kuei-Li Lin 1,
More informationSynonyms. Nephrogenic metaplasia Mesonephric adenoma
Nephrogenic Adenoma Synonyms Nephrogenic metaplasia Mesonephric adenoma Definition Benign epithelial lesion of urinary tract with tubular, glandular, papillary growth pattern Most frequently in the urinary
More information3/24/2017 DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS. Disclosure of Relevant Financial Relationships
DENDRITIC CELL NEOPLASMS: HISTOLOGY, IMMUNOHISTOCHEMISTRY, AND MOLECULAR GENETICS Jason L. Hornick, M.D., Ph.D. Director of Surgical Pathology and Immunohistochemistry Brigham and Women s Hospital Professor
More informationCase Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms
Hindawi Publishing Corporation Volume 2015, Article ID 153932, 5 pages http://dx.doi.org/10.1155/2015/153932 Case Report Tumor-to-Tumor Metastasis: Lung Carcinoma Metastasizing to Thyroid Neoplasms Shiuan-Li
More informationGross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of
Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.
More informationSquamous Cell Carcinoma of Thyroid: possible thymic origin, so-called ITET/CASTLE 2012/03/22
Squamous Cell Carcinoma of Thyroid: possible thymic origin, so-called ITET/CASTLE 2012/03/22 History of ITET/CASTLE First Report Gross Appearance and Prognosis 1) Miyauchi A et al: Intrathyroidal epithelial
More informationGeneral: Brain tumors are lesions that have mass effect distorting the normal tissue and often result in increased intracranial pressure.
1 Lecture Objectives Know the histologic features of the most common tumors of the CNS. Know the differences in behavior of the different tumor types. Be aware of the treatment modalities in the various
More informationPOORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT?
POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT? AGGRESSIVE THYROID CANCERS PAPILLARY CARCINOMA CERTAIN SUBTYPES POORLY DIFFERENTIATED CARCINOMA HIGH GRADE DIFFERENTIATED
More informationGOBLET CELL CARCINOID. Hanlin L. Wang, MD, PhD University of California Los Angeles
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationGOBLET CELL CARCINOID
GOBLET CELL CARCINOID Hanlin L. Wang, MD, PhD University of California Los Angeles Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee) in a position to
More informationNote: The cause of testicular neoplasms remains unknown
- In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.
More informationMammary analogue secretory carcinoma of salivary gland A case report of new entity
Case Report Mammary analogue secretory carcinoma of salivary gland A case report of new entity Vaibhav Bhika Bari 1*, Sandhya Unmesh Bholay 2 1 Assistant Professor, 2 Associate Professor Rajiv Gandhi Medical
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationCutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement
Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchcock Medical Center
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationPathology Mystery and Surprise
Pathology Mystery and Surprise Tim Smith, MD Director Anatomic Pathology Medical University of South Carolina Disclosures No conflicts to declare Some problem cases Kidney tumor Scalp tumor Bladder tumor
More informationCase Report Paranasal Sinus Neuroendocrine Carcinoma: A Case Report and Review of the Literature
Hindawi Publishing Corporation Case Reports in Oncological Medicine Volume 2013, Article ID 728479, 5 pages http://dx.doi.org/10.1155/2013/728479 Case Report Paranasal Sinus Neuroendocrine Carcinoma: A
More information2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE. Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT
2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT 2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE AUTHORS : PROSTATE CHAPTER
More informationDiagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018
Diagnostic accuracy of percutaneous renal tumor biopsy May 10 th 2018 Dr. Tzahi Neuman Dep.Of Pathology Hadassah Medical Center Jerusalem, Israel, (tneuman@hadassah.org.il) Disclosure: 1 no conflicts of
More informationDiagnostically Challenging Cases in Gynecologic Pathology
Diagnostically Challenging Cases in Gynecologic Pathology Eric C. Huang, M.D., Ph.D. Department of Pathology and Laboratory Medicine University of California, Davis Medical Center Case 1 Presentation 38
More informationBenign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more
Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more common on the trunk; but extremities, head and neck are
More informationSalivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches
Salivary gland tumor cytologic and histologic correlation: Algorithmic and risk stratification based approaches Christopher C. Griffith, MD, PhD Raja R. Seethala, MD 1. Salivary gland tumor cytology: A
More informationARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.
1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological
More information4/17/2015. Case 1. A 37 year old man with a 2.2 cm solitary left thyroid mass.
Case 1 A 37 year old man with a 2.2 cm solitary left thyroid mass. Case 1 Case 1 1 Case 1: Diagnosis? A. Benign B. Atypia of undetermined significance/follicular lesion of undetermined significance C.
More informationDisclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012
Disclosures Parathyroid Pathology I have nothing to disclose Annemieke van Zante MD/PhD Assistant Professor of Clinical Pathology Associate Chief of Cytopathology Objectives 1. Review the pathologic features
More informationB. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.
B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a
More informationG3.02 The malignant potential of the neoplasm should be recorded. CG3.02a
G3.02 The malignant potential of the neoplasm should be recorded. CG3.02a Conventional adrenocortical neoplasm. Each of the below parameters is scored 0 when absent and 1 when present. 3 or more of these
More informationSporadic Hemangioblastoma of the Kidney: a rare renal tumor
Liu et al. Diagnostic Pathology 2012, 7:49 CASE REPORT Open Access Sporadic Hemangioblastoma of the Kidney: a rare renal tumor Yang Liu 1,2, Xue-shan Qiu 1,2* and En-Hua Wang 1,2 Abstract: Hemangioblastoma
More informationFrom Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport
From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative
More informationUSCAP 2012: Companion Meeting of the AAOOP. Update on lacrimal gland neoplasms: Molecular pathology of interest
USCAP 2012: Companion Meeting of the AAOOP Vancouver BC, Canada, March 17, 2012 Update on lacrimal gland neoplasms: Molecular pathology of interest Valerie A. White MD, MHSc, FRCPC Department of Pathology
More informationNeuroendocrine carcinomas (carcinoids) of the thymus
Neuroendocrine carcinomas (carcinoids) of the thymus Cesar A. Moran, MD Professor of Pathology Director of Thoracic Pathology M D Anderson Cancer Center Houston, TX Primary thymic neuroendocrine carcinomas
More informationA 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.
November 2015 Case of the Month A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy. Contributed by: Rasha Salama, M.D., IU Department of Pathology and Laboratory Medicine
More informationApplications of IHC. Determination of the primary site in metastatic tumors of unknown origin
Applications of IHC Determination of the primary site in metastatic tumors of unknown origin Classification of tumors that appear 'undifferentiated' by standard light microscopy Precise classification
More informationTumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia
Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia Sílvia Bagué Servei de Patologia Hospital de Sant Pau Barcelona Soft tissue sarcomas Heterogeneous group
More informationUpdate in Salivary Gland Pathology. Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016
Update in Salivary Gland Pathology Benjamin L. Witt University of Utah/ARUP Laboratories February 9, 2016 Objectives Review the different appearances of a selection of salivary gland tumor types Establish
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationTHYMIC CARCINOMAS AN UPDATE
THYMIC CARCINOMAS AN UPDATE Mark R. Wick, M.D. University of Virginia Medical Center Charlottesville, VA CARCINOMA OF THE THYMUS General Clinical Features No apparent gender predilection Age range of 35-75
More informationBilateral Synchronous Ectopic Ethmoid Sinus Olfactory Neuroblastoma: A Case Report
ISSN 1941-5923 DOI: 10.12659/AJCR.897623 Received: 2016.01.17 Accepted: 2016.02.08 Published: 2016.04.21 Bilateral Synchronous Ectopic Ethmoid Sinus Olfactory Neuroblastoma: A Case Report Authors Contribution:
More informationThe Small Round Blue Cell Tumors of the Sinonasal Area
Head and Neck Pathol (2010) 4:84 93 DOI 10.1007/s12105-009-0158-6 PROCEEDINGS OF THE 2010 NORTH AMERICAN SOCIETY OF HEAD AND NECK PATHOLOGY COMPANION MEETING (WASHINGTON, DC) The Small Round Blue Cell
More information4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD
MUSC Pathology Symposium Kiawah Island April 18, 2018 Jesse K. McKenney, MD 1 Urothelial Carcinoma with Alternative Differentiation 2 Urothelial Carcinoma with Alternative Differentiation Recognition as
More information04/13/2017. Sinonasal Pathology. Sinonasal Tract Pathology Outline. 24 th Annual Seminar in Pathology Pittsburgh, PA April 27, 2017
Sinonasal Pathology 24 th Annual Seminar in Pathology Pittsburgh, PA April 27, 2017 Bruce M. Wenig, MD Moffitt Cancer Center Tampa, FL Sinonasal Tract Pathology Outline Sinonasal (Schneiderian) papillomas
More informationCytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics. Mercè Jordà, University of Miami
Cytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics Mercè Jordà, University of Miami Mortality Lung cancer is the most frequent cause of cancer incidence and mortality
More informationOncocytic carcinoma: A rare malignancy of the parotid gland
ISPUB.COM The Internet Journal of Pathology Volume 8 Number 2 Oncocytic carcinoma: A rare malignancy of the parotid gland K Mardi, J Sharma Citation K Mardi, J Sharma.. The Internet Journal of Pathology.
More informationInsulinoma-associated protein (INSM1) is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens
Insulinoma-associated protein (INSM1) is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens Kartik Viswanathan, M.D., Ph.D New York Presbyterian - Weill
More informationKidney Case 1 SURGICAL PATHOLOGY REPORT
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
More informationFinancial disclosures
Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement By Konstantinos Linos MD, FCAP, FASDP Bone, Soft Tissue and Dermatopathology Assistant Professor of Pathology Dartmouth-Hitchc Geisel School of
More informationNormal endometrium: A, proliferative. B, secretory.
Normal endometrium: A, proliferative. B, secretory. Nội mạc tử cung Nội mạc tử cung Cyclic changes in endometrium.. Approximate relationship of useful microscopic changes. Arias-Stella reaction in endometrial
More information